Ricoh and SimBioSys Partner on AI-Powered 3D Models for Personalized Breast Cancer Treatment

Ricoh USA, known for its expertise in custom medical device design through Ricoh 3D for Healthcare, is teaming up with SimBioSys, a tech company focused on AI integration and computational modeling. Together, the two companies recently announced a collaboration focused on exploring cutting-edge technologies for the treatment of breast cancer. This initiative aims to closely examine the potential of artificial intelligence (AI) combined with advanced 3D printing techniques to improve surgical procedures and personalize care for patients facing breast cancer. The aim is to create medical solutions that could revolutionize the way breast cancer is treated and managed.

By joining forces, these two companies are committed to pushing back the boundaries of medical innovation by combining SimBioSys’ cutting-edge artificial intelligence with Ricoh’s 3D printing know-how. The focus will be on creating highly accurate, patient-specific breast cancer models.

(Photo Credits: SimBioSys)

AI and 3D Printing for Breast Cancer Treatment

During the American Society of Breast Surgeons conference, held earlier this month from April 11th to 14th, 2024, Ricoh 3D for Healthcare and SimBioSys showcased their latest advancements. They introduced the pioneering breast cancer models, born from the synergy of artificial intelligence and 3D printing. The event highlighted the capabilities and potential of the two companies’ joint technologies. Speaking on their partnership, Gary Turner, Managing Director at Ricoh USA, stated, “Through a collaboration with SimBioSys, we hope to not just envision a new future for medical treatment but help actively create it. Our dedication to precision and personalization in breast cancer care is about to be showcased at ASBrS, reflecting the potential of our combined efforts.”